Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;30(8):1559-67.
doi: 10.1007/s10554-014-0487-8. Epub 2014 Jul 10.

Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging

Affiliations

Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging

Jiwon Kim et al. Int J Cardiovasc Imaging. 2014 Dec.

Abstract

Left ventricular (LV) remodeling and myocardial fibrosis have been linked to adverse heart failure outcomes. Mid wall late gadolinium enhancement (MW-LGE) on cardiac magnetic resonance (CMR) imaging is well-associated with non-ischemic cardiomyopathy (NICM), but prevalence in ischemic cardiomyopathy (ICM) and association with remodeling are unknown. The population comprised patients with systolic dysfunction [LV ejection fraction (LVEF ≤ 40 %)]. CMR was used to identify MW-LGE, conventionally defined as fibrosis of the mid-myocardial or epicardial aspect of the LV septum. 285 patients were studied. MW-LGE was present in 12 %, and was tenfold more common with NICM (32 %) versus ICM (3 %, p < 0.001). However, owing to higher prevalence of ICM, 15 % of patients with MW-LGE had ICM. LV wall stress was higher (p = 0.02) among patients with, versus those without, MW-LGE despite similar systolic blood pressure (p = 0.24). In multivariate analysis, MW-LGE was associated with CMR-quantified LV end-diastolic volume (p = 0.03) independent of LVEF and mass. Incorporation of clinical and imaging variables demonstrated MW-LGE to be associated with higher LV end-diastolic volume (OR 1.13, CI 1.004-1.27 per 10 ml/m(2), p = 0.04) after controlling for presence of NICM (OR 16.0, CI 5.8-44.1, p < 0.001). While more common in NICM, MW-LGE can occur in ICM and is a marker of LV chamber dilation irrespective of cardiomyopathic etiology.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interests: None

Figures

Figure 1
Figure 1. Typical Examples of Mid-Wall Fibrosis
Representative examples of MW-LGE (red arrows) among patients with angiography-evidenced NICM (1A) and ICM (1B). Note presence MW-LGE with concomitant inferior wall myocardial infarction (blue arrow) in the context of ICM (1B).
Figure 2
Figure 2. Mid-Wall Fibrosis Prevalence in Relation to LV Remodeling
Prevalence of MW-LGE in relation to population-based tertiles of LV end-diastolic volume (2A) and wall stress (2B). As shown, MW-LGE prevalence increased stepwise in relation to both LV remodeling parameters (both p<0.05), although magnitude of difference between highest and lowest tertiles were greater for LV volume than for the aggregate parameter of LV wall stress.
Figure 3
Figure 3. Mid-Wall Fibrosis Size in Relation to LV Remodeling
LV end-diastolic volume (mean ± SD) among patients without MW-LGE (black bar), as well as MW-LGE-affected patients (grey bars) stratified into two groups based on fibrosis size (right = top, left = bottom 50%). Note that both groups of MW-LGE-affected patients had larger LV chamber volumes than did those without MW-LGE, with non-significant differences between MW-LGE-affected patients stratified by fibrosis size.

Comment in

Similar articles

Cited by

References

    1. Migrino RQ, Young JB, Ellis SG, White HD, Lundergan CF, Miller DP, et al. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators. Circulation. 1997;96:116–121. - PubMed
    1. Lee TH, Hamilton MA, Stevenson LW, Moriguchi JD, Fonarow GC, Child JS, et al. Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol. 1993;72:672–676. - PubMed
    1. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327:669–677. - PubMed
    1. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977–984. - PubMed
    1. Harada K, Sugaya T, Murakami K, Yazaki Y, Komuro I. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation. 1999;100:2093–2099. - PubMed

Publication types

MeSH terms

LinkOut - more resources